-
New threshold sugar content recommended
This step by NIN could impact many branded soft drinks, juices, cereals, cookies and ice-creams and marks a conspicuous departure from the earlier pra
-
1 in 9 Indians likely to have cancer
While many insurers offer cancer-specific insurance policies, others subsume cancer treatment under the critical illness cover. As per data, the med
-
Diabetes can damage your body and pocket, both
Currently, there are only 4-5 policies that cater specifically to the diabetics. While they may offer better coverage as compared to general health in
-
Covid-19: Single dose vaccine not enough to provide significant protection: Study
A study conducted by Sir Ganga Ram Hospital in Delhi states that a single dose of a Covid-19 vaccine is not enough to provide substantial protection.
-
Covishield, Covaxin mixing can give better results: ICMR
A combination of Covishield followed by Covaxin was not only safe but also elicited better immunogenicity according to the ICMR's study.
-
Two-thirds of Indians have Covid antibodies: Sero survey
The ICMR's fourth sero survey has shown that about 40 crore people are still vulnerable to the Covid-19 infection
-
'95% of Covid deaths can be prevented by 2 vaccine doses'
India has so far administered 39.96 crore vaccine doses
-
'More data needed to decide whether kids can be inoculated'
Till we have more data available on vaccination of children we will not be in a position to vaccinate children at large, says Dr Balram Bharagava
-
Covid-19: India records 2.76 lakh new cases; daily deaths below 4,000
A total of 3,874 fatalities due to Covid-19 were registered in a span of 24 hours
-
Covid-19: Cipla signs pact with Eli Lilly to produce, sell COVID-19 treatment drug
Amid spiraling cases of covid-19 in the country, drug firms have been collaborating to come out with drugs to treat the highly infectious disease.
